MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - SEC Filings

Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find MGRX SEC filings?

Rallies organizes MGRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

MGRX Key Metrics

Key financial metrics for MGRX
MetricValue
Price$0.40
Market Cap$6.87M
P/E Ratio-0.19
EPS$-2.17
Dividend Yield0.00%
52-Week High$7.66
52-Week Low$0.16
Volume69
Avg Volume0
Revenue (TTM)$456.02K
Net Income$-20.64M
Gross Margin54.91%

Latest MGRX News

Recent MGRX Insider Trades

  • JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
  • JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
  • JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.

MGRX Analyst Consensus

MGRX analyst coverage data. Average price target: $0.00.

Common questions about MGRX

Where can I find MGRX SEC filings?
Rallies organizes MGRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show MGRX 10-K and 10-Q filings?
Rallies organizes MGRX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is MGRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.
MGRX

MGRX